Electrocardiograph (ECG) Market By Product (Resting Electrocardiograph (ECG), Stress Electrocardiograph (ECG), Holter Monitors, Others), By End User (Hospitals & Clinics, Home Settings & Ambulatory Surgical Centers (ASCs), Others), By Lead Type (Single Lead ECG, 2 Lead ECG, 3 Lead ECG, 6 Lead ECG, 12-Lead ECG): Global Opportunity Analysis and Industry Forecast, 2020-2030

Electrocardiograph (ECG) Market

ECG device is the most commonly used device as primary diagnosis of heart-related ailments. This is attributed to the fact that ECG interpretation is an efficient method to measure and diagnose arrhythmia as well as adverse health conditions that are associated with abnormal heart beat. In addition, according to CDC, arrhythmias affect more than 4 million patients along with approximately half a million deaths each year in the U.S. Thus, increase in need to perform early and accurate diagnosis of cardiovascular diseases propels the growth of the ECG market size. In addition, rise in prevalence of cardiovascular diseases along with soaring old age population propels the market growth. Moreover, the introduction of novel ECG devices such as handheld ECG devices and ECG devices integrated with artificial intelligence systems supplements the growth of the ECG market share. However, lack of awareness regarding early prevention of cardiovascular diseases in developing economies, unstable reimbursement strategies for ECG devices, and increase in market saturation hamper the market growth. On the contrary, untapped emerging markets and increase in number of mergers, acquisitions, and product launches by market players are expected to offer profitable opportunities for the expansion of ECG market analysis.

The COVID-19 outbreak is anticipated to have a negative impact on the growth of the ECG industry, as most hospitals were not operating due to COVID-19 and the ongoing lockdowns in many countries. The spread of COVID-19 led to a major public health issue. COVID-19 affected the ECG market forecast, owing to lack of visits to healthcare facilities such as hospitals and clinics. Moreover, it affected workforce and staffing issues as well as procedural prioritization. Thus, the abovementioned issues affected the ECG Market growth due to cancellation of scheduled visits for primary care at hospitals and reflecting patients concern about infection.

According to Onkar Sumant, Manager, Healthcare at , “Recent technological advancements in ECG devices with enhanced features such as mobile ECG devices with a wireless system that can transmit data to monitoring stations and improved detection rates boost the ECG market growth. In addition, increase in awareness regarding preventive healthcare among people increased the frequency of electrocardiography, thereby propelling the market growth”.

KEY FINDINGS OF STUDY

On the basis of product, the resting electrocardiograph (ECG) segment was the highest contributor to the ECG industry in 2020.

Based on of end user, the hospitals and clinics segment was the highest contributor to the market in 2020.

Depending on lead type, the 6 lead ECG segment was the highest contributor to the market in 2020.

Region wise, North America garnered the largest revenue share in 2020, whereas Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period. North America accounted for a majority of the global ECG market size in 2020, and is anticipated to remain dominant during the forecast period due to high prevalence of cardiovascular diseases, increased healthcare expenditure, and large geriatric population base.

Overview

The global electrocardiograph (ECG) market was valued at $8,349.00 million in 2020, and is projected to reach $18,436.70 million by 2030, registering a CAGR of 8.3% from 2021 to 2030. 

ECG is a noninvasive technique for recording electrical activities of heartbeat over a span of time. Every heartbeat generates an electrical impulse that is captured with the help of electrodes rested on the body of a patient. Electrodes sense the tiny electrical modifications on the skin that happen from the depolarizing of heart muscle during every heartbeat. ECG devices are used to record the heart activities through electric signals. These devices are amplified on the ECG monitor. ECG devices are essentially adopted across various medical set-ups to diagnose different types of heart diseases and arrhythmias in people, thereby assisting the appropriate therapy for cardiovascular diseases (CVD) patients.

Increase in incidence of cardiovascular diseases and lifestyle associated diseases such as ischemic heart disease (IHD), hypertensive heart disease, stroke, and peripheral artery diseases is anticipated to drive the market growth. Surge in geriatric population base, improvement in healthcare infrastructure, and supportive reimbursement policies are expected to drive the growth of the ECG market. Furthermore, continuous advancements in technologies for ECG devices and introduction of remote monitoring devices are expected to fuel the growth of the market during the forecast period. Developing nations witness potential growth opportunities in comparison with developed countries, owing to the fact that the market of developed nations is almost saturated. In addition, developing nations are expected to witness lucrative growth opportunities, owing to favorable government policies such as investments to minimize the cost for treatment procedures in healthcare centers, increase in expenditure in healthcare, and largely untapped market potential.

However, lack of awareness regarding the use of ECG for diagnosis of diseases hampers the market growth. Furthermore, dearth of skilled professionals and service providers is presenting major issues and challenges for the market growth.

The global ECG market is segmented into product, end user, lead type, and region. By product, the market is categorized into resting electrocardiograph, stress electrocardiograph, and Holter monitors and others.

Depending on end user, it is categorized in hospitals & clinics, home setting & ambulatory surgical centers (ASCs), and others.

By lead type, it segregated into single lead ECG, 2 lead ECG, 3 lead ECG, 6 lead ECG, and 12 lead ECG.

Region wise, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Arabia, South Africa, and LAMEA).

The major companies profiled in the report include Ambu A/S, Baxter International Inc., BPL Medical Technologies Private Limited, Fukuda Denshi Co. Ltd., Johnson & Johnson, Koninklijke Philips N.V., Medtronic Plc., Nihon Kohden Corporation, Schiller AG, and Shenzhen Mindray Bio-Medical Electronics Co.

KEY BENEFITS FOR STAKEHOLDERS

    The report provides an in-depth analysis of the global ECG Market size along with the current trends and future estimations to elucidate the imminent investment pockets.

    It offers market analysis from 2021 to 2030, which is expected to enable the stakeholders to capitalize on the prevailing opportunities in the market.

    A comprehensive analysis of the region assists to understand the regional market and facilitate strategic business planning and determine prevailing opportunities.

    The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global ECG Market growth.

Key Market Segments

MINDRAY MEDICAL INTERNATIONAL LIMITE

Scope of Electrocardiograph (ECG) Market Report

1.1.Report description

1.2.Key market segments

1.3.Key benefits to the stakeholders

1.4.Research Methodology

1.4.1.Secondary research

1.4.2.Primary research

1.4.3.Analyst tools and models

2.1.Key findings of the study

2.2.CXO Perspective

3.1.Market definition and scope

3.2.Key findings

3.2.1.Top investment pockets

3.3.Porter’s five forces analysis

3.4.Top player positioning

3.5.Market dynamics

3.5.1.Drivers

3.5.2.Restraints

3.5.3.Opportunities

3.6.COVID-19 Impact Analysis on the market

4.1 Overview

4.1.1 Market size and forecast

4.2 Resting Electrocardiograph (ECG)

4.2.1 Key market trends, growth factors and opportunities

4.2.2 Market size and forecast, by region

4.2.3 Market analysis by country

4.3 Stress Electrocardiograph (ECG)

4.3.1 Key market trends, growth factors and opportunities

4.3.2 Market size and forecast, by region

4.3.3 Market analysis by country

4.4 Holter Monitors

4.4.1 Key market trends, growth factors and opportunities

4.4.2 Market size and forecast, by region

4.4.3 Market analysis by country

4.5 Others

4.5.1 Key market trends, growth factors and opportunities

4.5.2 Market size and forecast, by region

4.5.3 Market analysis by country

5.1 Overview

5.1.1 Market size and forecast

5.2 Hospitals & Clinics

5.2.1 Key market trends, growth factors and opportunities

5.2.2 Market size and forecast, by region

5.2.3 Market analysis by country

5.3 Home Settings & Ambulatory Surgical Centers (ASCs)

5.3.1 Key market trends, growth factors and opportunities

5.3.2 Market size and forecast, by region

5.3.3 Market analysis by country

5.4 Others

5.4.1 Key market trends, growth factors and opportunities

5.4.2 Market size and forecast, by region

5.4.3 Market analysis by country

6.1 Overview

6.1.1 Market size and forecast

6.2 Single Lead ECG

6.2.1 Key market trends, growth factors and opportunities

6.2.2 Market size and forecast, by region

6.2.3 Market analysis by country

6.3 2 Lead ECG

6.3.1 Key market trends, growth factors and opportunities

6.3.2 Market size and forecast, by region

6.3.3 Market analysis by country

6.4 3 Lead ECG

6.4.1 Key market trends, growth factors and opportunities

6.4.2 Market size and forecast, by region

6.4.3 Market analysis by country

6.5 6 Lead ECG

6.5.1 Key market trends, growth factors and opportunities

6.5.2 Market size and forecast, by region

6.5.3 Market analysis by country

6.6 12-Lead ECG

6.6.1 Key market trends, growth factors and opportunities

6.6.2 Market size and forecast, by region

6.6.3 Market analysis by country

7.1 Overview

7.1.1 Market size and forecast

7.2 North America

7.2.1 Key trends and opportunities

7.2.2 North America Market size and forecast, by By Product

7.2.3 North America Market size and forecast, by By End User

7.2.4 North America Market size and forecast, by By Lead Type

7.2.5 North America Market size and forecast, by country

7.2.5.1 U.S.

7.2.5.1.1 Market size and forecast, by By Product

7.2.5.1.2 Market size and forecast, by By End User

7.2.5.1.3 Market size and forecast, by By Lead Type

7.2.5.2 Canada

7.2.5.2.1 Market size and forecast, by By Product

7.2.5.2.2 Market size and forecast, by By End User

7.2.5.2.3 Market size and forecast, by By Lead Type

7.2.5.3 Mexico

7.2.5.3.1 Market size and forecast, by By Product

7.2.5.3.2 Market size and forecast, by By End User

7.2.5.3.3 Market size and forecast, by By Lead Type

7.3 Europe

7.3.1 Key trends and opportunities

7.3.2 Europe Market size and forecast, by By Product

7.3.3 Europe Market size and forecast, by By End User

7.3.4 Europe Market size and forecast, by By Lead Type

7.3.5 Europe Market size and forecast, by country

7.3.5.1 Germany

7.3.5.1.1 Market size and forecast, by By Product

7.3.5.1.2 Market size and forecast, by By End User

7.3.5.1.3 Market size and forecast, by By Lead Type

7.3.5.2 France

7.3.5.2.1 Market size and forecast, by By Product

7.3.5.2.2 Market size and forecast, by By End User

7.3.5.2.3 Market size and forecast, by By Lead Type

7.3.5.3 United Kingdom

7.3.5.3.1 Market size and forecast, by By Product

7.3.5.3.2 Market size and forecast, by By End User

7.3.5.3.3 Market size and forecast, by By Lead Type

7.3.5.4 Italy

7.3.5.4.1 Market size and forecast, by By Product

7.3.5.4.2 Market size and forecast, by By End User

7.3.5.4.3 Market size and forecast, by By Lead Type

7.3.5.5 Spain

7.3.5.5.1 Market size and forecast, by By Product

7.3.5.5.2 Market size and forecast, by By End User

7.3.5.5.3 Market size and forecast, by By Lead Type

7.3.5.6 Rest of Europe

7.3.5.6.1 Market size and forecast, by By Product

7.3.5.6.2 Market size and forecast, by By End User

7.3.5.6.3 Market size and forecast, by By Lead Type

7.4 Asia-Pacific

7.4.1 Key trends and opportunities

7.4.2 Asia-Pacific Market size and forecast, by By Product

7.4.3 Asia-Pacific Market size and forecast, by By End User

7.4.4 Asia-Pacific Market size and forecast, by By Lead Type

7.4.5 Asia-Pacific Market size and forecast, by country

7.4.5.1 Japan

7.4.5.1.1 Market size and forecast, by By Product

7.4.5.1.2 Market size and forecast, by By End User

7.4.5.1.3 Market size and forecast, by By Lead Type

7.4.5.2 China

7.4.5.2.1 Market size and forecast, by By Product

7.4.5.2.2 Market size and forecast, by By End User

7.4.5.2.3 Market size and forecast, by By Lead Type

7.4.5.3 India

7.4.5.3.1 Market size and forecast, by By Product

7.4.5.3.2 Market size and forecast, by By End User

7.4.5.3.3 Market size and forecast, by By Lead Type

7.4.5.4 Australia

7.4.5.4.1 Market size and forecast, by By Product

7.4.5.4.2 Market size and forecast, by By End User

7.4.5.4.3 Market size and forecast, by By Lead Type

7.4.5.5 Malaysia

7.4.5.5.1 Market size and forecast, by By Product

7.4.5.5.2 Market size and forecast, by By End User

7.4.5.5.3 Market size and forecast, by By Lead Type

7.4.5.6 New Zealand

7.4.5.6.1 Market size and forecast, by By Product

7.4.5.6.2 Market size and forecast, by By End User

7.4.5.6.3 Market size and forecast, by By Lead Type

7.4.5.7 Rest of Asia-Pacific

7.4.5.7.1 Market size and forecast, by By Product

7.4.5.7.2 Market size and forecast, by By End User

7.4.5.7.3 Market size and forecast, by By Lead Type

7.5 LAMEA

7.5.1 Key trends and opportunities

7.5.2 LAMEA Market size and forecast, by By Product

7.5.3 LAMEA Market size and forecast, by By End User

7.5.4 LAMEA Market size and forecast, by By Lead Type

7.5.5 LAMEA Market size and forecast, by country

7.5.5.1 Brazil

7.5.5.1.1 Market size and forecast, by By Product

7.5.5.1.2 Market size and forecast, by By End User

7.5.5.1.3 Market size and forecast, by By Lead Type

7.5.5.2 South Africa

7.5.5.2.1 Market size and forecast, by By Product

7.5.5.2.2 Market size and forecast, by By End User

7.5.5.2.3 Market size and forecast, by By Lead Type

7.5.5.3 Egypt

7.5.5.3.1 Market size and forecast, by By Product

7.5.5.3.2 Market size and forecast, by By End User

7.5.5.3.3 Market size and forecast, by By Lead Type

7.5.5.4 Saudi Arabia

7.5.5.4.1 Market size and forecast, by By Product

7.5.5.4.2 Market size and forecast, by By End User

7.5.5.4.3 Market size and forecast, by By Lead Type

7.5.5.5 Rest of LAMEA

7.5.5.5.1 Market size and forecast, by By Product

7.5.5.5.2 Market size and forecast, by By End User

7.5.5.5.3 Market size and forecast, by By Lead Type

8.1. Introduction

8.2. Top winning strategies

8.3. Product Mapping of Top 10 Player

8.4. Competitive Dashboard

8.5. Competitive Heatmap

8.6. Key developments

9.1 NIHON KOHDEN CORPORATION

9.1.1 Company overview

9.1.2 Company snapshot

9.1.3 Operating business segments

9.1.4 Product portfolio

9.1.5 Business performance

9.1.6 Key strategic moves and developments

9.2 OSI SYSTEMS FUKUDA DENSHI CO LTD.

9.2.1 Company overview

9.2.2 Company snapshot

9.2.3 Operating business segments

9.2.4 Product portfolio

9.2.5 Business performance

9.2.6 Key strategic moves and developments

9.3 OPTO CIRCUITS LIMITED

9.3.1 Company overview

9.3.2 Company snapshot

9.3.3 Operating business segments

9.3.4 Product portfolio

9.3.5 Business performance

9.3.6 Key strategic moves and developments

9.4 PHILIPS HEALTHCARE (KONINKLIJKE PHILIPS N.V.)

9.4.1 Company overview

9.4.2 Company snapshot

9.4.3 Operating business segments

9.4.4 Product portfolio

9.4.5 Business performance

9.4.6 Key strategic moves and developments

9.5 SCHILLER AG

9.5.1 Company overview

9.5.2 Company snapshot

9.5.3 Operating business segments

9.5.4 Product portfolio

9.5.5 Business performance

9.5.6 Key strategic moves and developments

9.6 GE HEALTHCARE (GENERAL ELECTRIC COMPANY)

9.6.1 Company overview

9.6.2 Company snapshot

9.6.3 Operating business segments

9.6.4 Product portfolio

9.6.5 Business performance

9.6.6 Key strategic moves and developments

9.7 JOHNSON AND JOHNSON

9.7.1 Company overview

9.7.2 Company snapshot

9.7.3 Operating business segments

9.7.4 Product portfolio

9.7.5 Business performance

9.7.6 Key strategic moves and developments

9.8 MORTARA INSTRUMENT, INC.

9.8.1 Company overview

9.8.2 Company snapshot

9.8.3 Operating business segments

9.8.4 Product portfolio

9.8.5 Business performance

9.8.6 Key strategic moves and developments

9.9 MEDTRONIC PLC

9.9.1 Company overview

9.9.2 Company snapshot

9.9.3 Operating business segments

9.9.4 Product portfolio

9.9.5 Business performance

9.9.6 Key strategic moves and developments

9.10 MINDRAY MEDICAL INTERNATIONAL LIMITED

9.10.1 Company overview

9.10.2 Company snapshot

9.10.3 Operating business segments

9.10.4 Product portfolio

9.10.5 Business performance

9.10.6 Key strategic moves and development

LIST OF TABLES

TABLE 1. GLOBAL ELECTROCARDIOGRAPH (ECG) MARKET, BY BY PRODUCT, 2020-2030,($MILLION)

TABLE 2. ELECTROCARDIOGRAPH (ECG) MARKET REVENUE, FOR RESTING ELECTROCARDIOGRAPH (ECG), BY REGION , 2020-2030,($MILLION)

TABLE 3. ELECTROCARDIOGRAPH (ECG) MARKET RESTING ELECTROCARDIOGRAPH (ECG) BY COUNTRY, 2020-2030,($MILLION)

TABLE 4. ELECTROCARDIOGRAPH (ECG) MARKET REVENUE, FOR STRESS ELECTROCARDIOGRAPH (ECG), BY REGION , 2020-2030,($MILLION)

TABLE 5. ELECTROCARDIOGRAPH (ECG) MARKET STRESS ELECTROCARDIOGRAPH (ECG) BY COUNTRY, 2020-2030,($MILLION)

TABLE 6. ELECTROCARDIOGRAPH (ECG) MARKET REVENUE, FOR HOLTER MONITORS, BY REGION , 2020-2030,($MILLION)

TABLE 7. ELECTROCARDIOGRAPH (ECG) MARKET HOLTER MONITORS BY COUNTRY, 2020-2030,($MILLION)

TABLE 8. ELECTROCARDIOGRAPH (ECG) MARKET REVENUE, FOR OTHERS, BY REGION , 2020-2030,($MILLION)

TABLE 9. ELECTROCARDIOGRAPH (ECG) MARKET OTHERS BY COUNTRY, 2020-2030,($MILLION)

TABLE 10. GLOBAL ELECTROCARDIOGRAPH (ECG) MARKET, BY BY END USER, 2020-2030,($MILLION)

TABLE 11. ELECTROCARDIOGRAPH (ECG) MARKET REVENUE, FOR HOSPITALS & CLINICS, BY REGION , 2020-2030,($MILLION)

TABLE 12. ELECTROCARDIOGRAPH (ECG) MARKET HOSPITALS & CLINICS BY COUNTRY, 2020-2030,($MILLION)

TABLE 13. ELECTROCARDIOGRAPH (ECG) MARKET REVENUE, FOR HOME SETTINGS & AMBULATORY SURGICAL CENTERS (ASCS), BY REGION , 2020-2030,($MILLION)

TABLE 14. ELECTROCARDIOGRAPH (ECG) MARKET HOME SETTINGS & AMBULATORY SURGICAL CENTERS (ASCS) BY COUNTRY, 2020-2030,($MILLION)

TABLE 15. ELECTROCARDIOGRAPH (ECG) MARKET REVENUE, FOR OTHERS, BY REGION , 2020-2030,($MILLION)

TABLE 16. ELECTROCARDIOGRAPH (ECG) MARKET OTHERS BY COUNTRY, 2020-2030,($MILLION)

TABLE 17. GLOBAL ELECTROCARDIOGRAPH (ECG) MARKET, BY BY LEAD TYPE, 2020-2030,($MILLION)

TABLE 18. ELECTROCARDIOGRAPH (ECG) MARKET REVENUE, FOR SINGLE LEAD ECG, BY REGION , 2020-2030,($MILLION)

TABLE 19. ELECTROCARDIOGRAPH (ECG) MARKET SINGLE LEAD ECG BY COUNTRY, 2020-2030,($MILLION)

TABLE 20. ELECTROCARDIOGRAPH (ECG) MARKET REVENUE, FOR 2 LEAD ECG, BY REGION , 2020-2030,($MILLION)

TABLE 21. ELECTROCARDIOGRAPH (ECG) MARKET 2 LEAD ECG BY COUNTRY, 2020-2030,($MILLION)

TABLE 22. ELECTROCARDIOGRAPH (ECG) MARKET REVENUE, FOR 3 LEAD ECG, BY REGION , 2020-2030,($MILLION)

TABLE 23. ELECTROCARDIOGRAPH (ECG) MARKET 3 LEAD ECG BY COUNTRY, 2020-2030,($MILLION)

TABLE 24. ELECTROCARDIOGRAPH (ECG) MARKET REVENUE, FOR 6 LEAD ECG, BY REGION , 2020-2030,($MILLION)

TABLE 25. ELECTROCARDIOGRAPH (ECG) MARKET 6 LEAD ECG BY COUNTRY, 2020-2030,($MILLION)

TABLE 26. ELECTROCARDIOGRAPH (ECG) MARKET REVENUE, FOR 12-LEAD ECG, BY REGION , 2020-2030,($MILLION)

TABLE 27. ELECTROCARDIOGRAPH (ECG) MARKET 12-LEAD ECG BY COUNTRY, 2020-2030,($MILLION)

TABLE 28. ELECTROCARDIOGRAPH (ECG) MARKET, BY REGION, 2020-2030,($MILLION)

TABLE 29. NORTH AMERICA ELECTROCARDIOGRAPH (ECG) MARKET, BY BY PRODUCT, 2020-2030,($MILLION)

TABLE 30. NORTH AMERICA ELECTROCARDIOGRAPH (ECG) MARKET, BY BY END USER, 2020-2030,($MILLION)

TABLE 31. NORTH AMERICA ELECTROCARDIOGRAPH (ECG) MARKET, BY BY LEAD TYPE, 2020-2030,($MILLION)

TABLE 32. NORTH AMERICA ELECTROCARDIOGRAPH (ECG) MARKET, BY COUNTRY, 2020-2030,($MILLION)

TABLE 33. U.S. ELECTROCARDIOGRAPH (ECG) MARKET BY BY PRODUCT 2020-2030,($MILLION)

TABLE 34. U.S. ELECTROCARDIOGRAPH (ECG) MARKET BY BY END USER 2020-2030,($MILLION)

TABLE 35. U.S. ELECTROCARDIOGRAPH (ECG) MARKET BY BY LEAD TYPE 2020-2030,($MILLION)

TABLE 36. CANADA ELECTROCARDIOGRAPH (ECG) MARKET BY BY PRODUCT 2020-2030,($MILLION)

TABLE 37. CANADA ELECTROCARDIOGRAPH (ECG) MARKET BY BY END USER 2020-2030,($MILLION)

TABLE 38. CANADA ELECTROCARDIOGRAPH (ECG) MARKET BY BY LEAD TYPE 2020-2030,($MILLION)

TABLE 39. MEXICO ELECTROCARDIOGRAPH (ECG) MARKET BY BY PRODUCT 2020-2030,($MILLION)

TABLE 40. MEXICO ELECTROCARDIOGRAPH (ECG) MARKET BY BY END USER 2020-2030,($MILLION)

TABLE 41. MEXICO ELECTROCARDIOGRAPH (ECG) MARKET BY BY LEAD TYPE 2020-2030,($MILLION)

TABLE 42. EUROPE ELECTROCARDIOGRAPH (ECG) MARKET, BY BY PRODUCT, 2020-2030,($MILLION)

TABLE 43. EUROPE ELECTROCARDIOGRAPH (ECG) MARKET, BY BY END USER, 2020-2030,($MILLION)

TABLE 44. EUROPE ELECTROCARDIOGRAPH (ECG) MARKET, BY BY LEAD TYPE, 2020-2030,($MILLION)

TABLE 45. EUROPE ELECTROCARDIOGRAPH (ECG) MARKET, BY COUNTRY, 2020-2030,($MILLION)

TABLE 46. GERMANY ELECTROCARDIOGRAPH (ECG) MARKET BY BY PRODUCT 2020-2030,($MILLION)

TABLE 47. GERMANY ELECTROCARDIOGRAPH (ECG) MARKET BY BY END USER 2020-2030,($MILLION)

TABLE 48. GERMANY ELECTROCARDIOGRAPH (ECG) MARKET BY BY LEAD TYPE 2020-2030,($MILLION)

TABLE 49. FRANCE ELECTROCARDIOGRAPH (ECG) MARKET BY BY PRODUCT 2020-2030,($MILLION)

TABLE 50. FRANCE ELECTROCARDIOGRAPH (ECG) MARKET BY BY END USER 2020-2030,($MILLION)

TABLE 51. FRANCE ELECTROCARDIOGRAPH (ECG) MARKET BY BY LEAD TYPE 2020-2030,($MILLION)

TABLE 52. UNITED KINGDOM ELECTROCARDIOGRAPH (ECG) MARKET BY BY PRODUCT 2020-2030,($MILLION)

TABLE 53. UNITED KINGDOM ELECTROCARDIOGRAPH (ECG) MARKET BY BY END USER 2020-2030,($MILLION)

TABLE 54. UNITED KINGDOM ELECTROCARDIOGRAPH (ECG) MARKET BY BY LEAD TYPE 2020-2030,($MILLION)

TABLE 55. ITALY ELECTROCARDIOGRAPH (ECG) MARKET BY BY PRODUCT 2020-2030,($MILLION)

TABLE 56. ITALY ELECTROCARDIOGRAPH (ECG) MARKET BY BY END USER 2020-2030,($MILLION)

TABLE 57. ITALY ELECTROCARDIOGRAPH (ECG) MARKET BY BY LEAD TYPE 2020-2030,($MILLION)

TABLE 58. SPAIN ELECTROCARDIOGRAPH (ECG) MARKET BY BY PRODUCT 2020-2030,($MILLION)

TABLE 59. SPAIN ELECTROCARDIOGRAPH (ECG) MARKET BY BY END USER 2020-2030,($MILLION)

TABLE 60. SPAIN ELECTROCARDIOGRAPH (ECG) MARKET BY BY LEAD TYPE 2020-2030,($MILLION)

TABLE 61. REST OF EUROPE ELECTROCARDIOGRAPH (ECG) MARKET BY BY PRODUCT 2020-2030,($MILLION)

TABLE 62. REST OF EUROPE ELECTROCARDIOGRAPH (ECG) MARKET BY BY END USER 2020-2030,($MILLION)

TABLE 63. REST OF EUROPE ELECTROCARDIOGRAPH (ECG) MARKET BY BY LEAD TYPE 2020-2030,($MILLION)

TABLE 64. ASIA-PACIFIC ELECTROCARDIOGRAPH (ECG) MARKET, BY BY PRODUCT, 2020-2030,($MILLION)

TABLE 65. ASIA-PACIFIC ELECTROCARDIOGRAPH (ECG) MARKET, BY BY END USER, 2020-2030,($MILLION)

TABLE 66. ASIA-PACIFIC ELECTROCARDIOGRAPH (ECG) MARKET, BY BY LEAD TYPE, 2020-2030,($MILLION)

TABLE 67. ASIA-PACIFIC ELECTROCARDIOGRAPH (ECG) MARKET, BY COUNTRY, 2020-2030,($MILLION)

TABLE 68. JAPAN ELECTROCARDIOGRAPH (ECG) MARKET BY BY PRODUCT 2020-2030,($MILLION)

TABLE 69. JAPAN ELECTROCARDIOGRAPH (ECG) MARKET BY BY END USER 2020-2030,($MILLION)

TABLE 70. JAPAN ELECTROCARDIOGRAPH (ECG) MARKET BY BY LEAD TYPE 2020-2030,($MILLION)

TABLE 71. CHINA ELECTROCARDIOGRAPH (ECG) MARKET BY BY PRODUCT 2020-2030,($MILLION)

TABLE 72. CHINA ELECTROCARDIOGRAPH (ECG) MARKET BY BY END USER 2020-2030,($MILLION)

TABLE 73. CHINA ELECTROCARDIOGRAPH (ECG) MARKET BY BY LEAD TYPE 2020-2030,($MILLION)

TABLE 74. INDIA ELECTROCARDIOGRAPH (ECG) MARKET BY BY PRODUCT 2020-2030,($MILLION)

TABLE 75. INDIA ELECTROCARDIOGRAPH (ECG) MARKET BY BY END USER 2020-2030,($MILLION)

TABLE 76. INDIA ELECTROCARDIOGRAPH (ECG) MARKET BY BY LEAD TYPE 2020-2030,($MILLION)

TABLE 77. AUSTRALIA ELECTROCARDIOGRAPH (ECG) MARKET BY BY PRODUCT 2020-2030,($MILLION)

TABLE 78. AUSTRALIA ELECTROCARDIOGRAPH (ECG) MARKET BY BY END USER 2020-2030,($MILLION)

TABLE 79. AUSTRALIA ELECTROCARDIOGRAPH (ECG) MARKET BY BY LEAD TYPE 2020-2030,($MILLION)

TABLE 80. MALAYSIA ELECTROCARDIOGRAPH (ECG) MARKET BY BY PRODUCT 2020-2030,($MILLION)

TABLE 81. MALAYSIA ELECTROCARDIOGRAPH (ECG) MARKET BY BY END USER 2020-2030,($MILLION)

TABLE 82. MALAYSIA ELECTROCARDIOGRAPH (ECG) MARKET BY BY LEAD TYPE 2020-2030,($MILLION)

TABLE 83. NEW ZEALAND ELECTROCARDIOGRAPH (ECG) MARKET BY BY PRODUCT 2020-2030,($MILLION)

TABLE 84. NEW ZEALAND ELECTROCARDIOGRAPH (ECG) MARKET BY BY END USER 2020-2030,($MILLION)

TABLE 85. NEW ZEALAND ELECTROCARDIOGRAPH (ECG) MARKET BY BY LEAD TYPE 2020-2030,($MILLION)

TABLE 86. REST OF ASIA-PACIFIC ELECTROCARDIOGRAPH (ECG) MARKET BY BY PRODUCT 2020-2030,($MILLION)

TABLE 87. REST OF ASIA-PACIFIC ELECTROCARDIOGRAPH (ECG) MARKET BY BY END USER 2020-2030,($MILLION)

TABLE 88. REST OF ASIA-PACIFIC ELECTROCARDIOGRAPH (ECG) MARKET BY BY LEAD TYPE 2020-2030,($MILLION)

TABLE 89. LAMEA ELECTROCARDIOGRAPH (ECG) MARKET, BY BY PRODUCT, 2020-2030,($MILLION)

TABLE 90. LAMEA ELECTROCARDIOGRAPH (ECG) MARKET, BY BY END USER, 2020-2030,($MILLION)

TABLE 91. LAMEA ELECTROCARDIOGRAPH (ECG) MARKET, BY BY LEAD TYPE, 2020-2030,($MILLION)

TABLE 92. LAMEA ELECTROCARDIOGRAPH (ECG) MARKET, BY COUNTRY, 2020-2030,($MILLION)

TABLE 93. BRAZIL ELECTROCARDIOGRAPH (ECG) MARKET BY BY PRODUCT 2020-2030,($MILLION)

TABLE 94. BRAZIL ELECTROCARDIOGRAPH (ECG) MARKET BY BY END USER 2020-2030,($MILLION)

TABLE 95. BRAZIL ELECTROCARDIOGRAPH (ECG) MARKET BY BY LEAD TYPE 2020-2030,($MILLION)

TABLE 96. SOUTH AFRICA ELECTROCARDIOGRAPH (ECG) MARKET BY BY PRODUCT 2020-2030,($MILLION)

TABLE 97. SOUTH AFRICA ELECTROCARDIOGRAPH (ECG) MARKET BY BY END USER 2020-2030,($MILLION)

TABLE 98. SOUTH AFRICA ELECTROCARDIOGRAPH (ECG) MARKET BY BY LEAD TYPE 2020-2030,($MILLION)

TABLE 99. EGYPT ELECTROCARDIOGRAPH (ECG) MARKET BY BY PRODUCT 2020-2030,($MILLION)

TABLE 100. EGYPT ELECTROCARDIOGRAPH (ECG) MARKET BY BY END USER 2020-2030,($MILLION)

TABLE 101. EGYPT ELECTROCARDIOGRAPH (ECG) MARKET BY BY LEAD TYPE 2020-2030,($MILLION)

TABLE 102. SAUDI ARABIA ELECTROCARDIOGRAPH (ECG) MARKET BY BY PRODUCT 2020-2030,($MILLION)

TABLE 103. SAUDI ARABIA ELECTROCARDIOGRAPH (ECG) MARKET BY BY END USER 2020-2030,($MILLION)

TABLE 104. SAUDI ARABIA ELECTROCARDIOGRAPH (ECG) MARKET BY BY LEAD TYPE 2020-2030,($MILLION)

TABLE 105. REST OF LAMEA ELECTROCARDIOGRAPH (ECG) MARKET BY BY PRODUCT 2020-2030,($MILLION)

TABLE 106. REST OF LAMEA ELECTROCARDIOGRAPH (ECG) MARKET BY BY END USER 2020-2030,($MILLION)

TABLE 107. REST OF LAMEA ELECTROCARDIOGRAPH (ECG) MARKET BY BY LEAD TYPE 2020-2030,($MILLION)

TABLE 108.NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT

TABLE 109.NIHON KOHDEN CORPORATION: OPERATING SEGMENTS

TABLE 110.NIHON KOHDEN CORPORATION: PRODUCT PORTFOLIO

TABLE 111.NIHON KOHDEN CORPORATION: NET SALES,

TABLE 112.NIHON KOHDEN CORPORATION: KEY STRATERGIES

TABLE 113.OSI SYSTEMS FUKUDA DENSHI CO LTD.: COMPANY SNAPSHOT

TABLE 114.OSI SYSTEMS FUKUDA DENSHI CO LTD.: OPERATING SEGMENTS

TABLE 115.OSI SYSTEMS FUKUDA DENSHI CO LTD.: PRODUCT PORTFOLIO

TABLE 116.OSI SYSTEMS FUKUDA DENSHI CO LTD.: NET SALES,

TABLE 117.OSI SYSTEMS FUKUDA DENSHI CO LTD.: KEY STRATERGIES

TABLE 118.OPTO CIRCUITS LIMITED: COMPANY SNAPSHOT

TABLE 119.OPTO CIRCUITS LIMITED: OPERATING SEGMENTS

TABLE 120.OPTO CIRCUITS LIMITED: PRODUCT PORTFOLIO

TABLE 121.OPTO CIRCUITS LIMITED: NET SALES,

TABLE 122.OPTO CIRCUITS LIMITED: KEY STRATERGIES

TABLE 123.PHILIPS HEALTHCARE (KONINKLIJKE PHILIPS N.V.): COMPANY SNAPSHOT

TABLE 124.PHILIPS HEALTHCARE (KONINKLIJKE PHILIPS N.V.): OPERATING SEGMENTS

TABLE 125.PHILIPS HEALTHCARE (KONINKLIJKE PHILIPS N.V.): PRODUCT PORTFOLIO

TABLE 126.PHILIPS HEALTHCARE (KONINKLIJKE PHILIPS N.V.): NET SALES,

TABLE 127.PHILIPS HEALTHCARE (KONINKLIJKE PHILIPS N.V.): KEY STRATERGIES

TABLE 128.SCHILLER AG: COMPANY SNAPSHOT

TABLE 129.SCHILLER AG: OPERATING SEGMENTS

TABLE 130.SCHILLER AG: PRODUCT PORTFOLIO

TABLE 131.SCHILLER AG: NET SALES,

TABLE 132.SCHILLER AG: KEY STRATERGIES

TABLE 133.GE HEALTHCARE (GENERAL ELECTRIC COMPANY): COMPANY SNAPSHOT

TABLE 134.GE HEALTHCARE (GENERAL ELECTRIC COMPANY): OPERATING SEGMENTS

TABLE 135.GE HEALTHCARE (GENERAL ELECTRIC COMPANY): PRODUCT PORTFOLIO

TABLE 136.GE HEALTHCARE (GENERAL ELECTRIC COMPANY): NET SALES,

TABLE 137.GE HEALTHCARE (GENERAL ELECTRIC COMPANY): KEY STRATERGIES

TABLE 138.JOHNSON AND JOHNSON: COMPANY SNAPSHOT

TABLE 139.JOHNSON AND JOHNSON: OPERATING SEGMENTS

TABLE 140.JOHNSON AND JOHNSON: PRODUCT PORTFOLIO

TABLE 141.JOHNSON AND JOHNSON: NET SALES,

TABLE 142.JOHNSON AND JOHNSON: KEY STRATERGIES

TABLE 143.MORTARA INSTRUMENT, INC.: COMPANY SNAPSHOT

TABLE 144.MORTARA INSTRUMENT, INC.: OPERATING SEGMENTS

TABLE 145.MORTARA INSTRUMENT, INC.: PRODUCT PORTFOLIO

TABLE 146.MORTARA INSTRUMENT, INC.: NET SALES,

TABLE 147.MORTARA INSTRUMENT, INC.: KEY STRATERGIES

TABLE 148.MEDTRONIC PLC: COMPANY SNAPSHOT

TABLE 149.MEDTRONIC PLC: OPERATING SEGMENTS

TABLE 150.MEDTRONIC PLC: PRODUCT PORTFOLIO

TABLE 151.MEDTRONIC PLC: NET SALES,

TABLE 152.MEDTRONIC PLC: KEY STRATERGIES

TABLE 153.MINDRAY MEDICAL INTERNATIONAL LIMITED: COMPANY SNAPSHOT

TABLE 154.MINDRAY MEDICAL INTERNATIONAL LIMITED: OPERATING SEGMENTS

TABLE 155.MINDRAY MEDICAL INTERNATIONAL LIMITED: PRODUCT PORTFOLIO

TABLE 156.MINDRAY MEDICAL INTERNATIONAL LIMITED: NET SALES,

TABLE 157.MINDRAY MEDICAL INTERNATIONAL LIMITED: KEY STRATERGIES LIST OF FIGURES

FIGURE 1.ELECTROCARDIOGRAPH (ECG) MARKET SEGMENTATION

FIGURE 2.ELECTROCARDIOGRAPH (ECG) MARKET,2020-2030

FIGURE 3.ELECTROCARDIOGRAPH (ECG) MARKET,2020-2030

FIGURE 4. TOP INVESTMENT POCKETS, BY REGION

FIGURE 5.PORTER FIVE-1

FIGURE 6.PORTER FIVE-2

FIGURE 7.PORTER FIVE-3

FIGURE 8.PORTER FIVE-4

FIGURE 9.PORTER FIVE-5

FIGURE 10.TOP PLAYER POSITIONING

FIGURE 11.ELECTROCARDIOGRAPH (ECG) MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES

FIGURE 12.ELECTROCARDIOGRAPH (ECG) MARKET,BY BY PRODUCT,2020(%)

FIGURE 13.COMPARATIVE SHARE ANALYSIS OF RESTING ELECTROCARDIOGRAPH (ECG) ELECTROCARDIOGRAPH (ECG) MARKET,2020-2030(%)

FIGURE 14.COMPARATIVE SHARE ANALYSIS OF STRESS ELECTROCARDIOGRAPH (ECG) ELECTROCARDIOGRAPH (ECG) MARKET,2020-2030(%)

FIGURE 15.COMPARATIVE SHARE ANALYSIS OF HOLTER MONITORS ELECTROCARDIOGRAPH (ECG) MARKET,2020-2030(%)

FIGURE 16.COMPARATIVE SHARE ANALYSIS OF OTHERS ELECTROCARDIOGRAPH (ECG) MARKET,2020-2030(%)

FIGURE 17.ELECTROCARDIOGRAPH (ECG) MARKET,BY BY END USER,2020(%)

FIGURE 18.COMPARATIVE SHARE ANALYSIS OF HOSPITALS & CLINICS ELECTROCARDIOGRAPH (ECG) MARKET,2020-2030(%)

FIGURE 19.COMPARATIVE SHARE ANALYSIS OF HOME SETTINGS & AMBULATORY SURGICAL CENTERS (ASCS) ELECTROCARDIOGRAPH (ECG) MARKET,2020-2030(%)

FIGURE 20.COMPARATIVE SHARE ANALYSIS OF OTHERS ELECTROCARDIOGRAPH (ECG) MARKET,2020-2030(%)

FIGURE 21.ELECTROCARDIOGRAPH (ECG) MARKET,BY BY LEAD TYPE,2020(%)

FIGURE 22.COMPARATIVE SHARE ANALYSIS OF SINGLE LEAD ECG ELECTROCARDIOGRAPH (ECG) MARKET,2020-2030(%)

FIGURE 23.COMPARATIVE SHARE ANALYSIS OF 2 LEAD ECG ELECTROCARDIOGRAPH (ECG) MARKET,2020-2030(%)

FIGURE 24.COMPARATIVE SHARE ANALYSIS OF 3 LEAD ECG ELECTROCARDIOGRAPH (ECG) MARKET,2020-2030(%)

FIGURE 25.COMPARATIVE SHARE ANALYSIS OF 6 LEAD ECG ELECTROCARDIOGRAPH (ECG) MARKET,2020-2030(%)

FIGURE 26.COMPARATIVE SHARE ANALYSIS OF 12-LEAD ECG ELECTROCARDIOGRAPH (ECG) MARKET,2020-2030(%)

FIGURE 27.ELECTROCARDIOGRAPH (ECG) MARKET BY REGION,2020

FIGURE 28.U.S. ELECTROCARDIOGRAPH (ECG) MARKET,2020-2030($MILLION)

FIGURE 29.CANADA ELECTROCARDIOGRAPH (ECG) MARKET,2020-2030($MILLION)

FIGURE 30.MEXICO ELECTROCARDIOGRAPH (ECG) MARKET,2020-2030($MILLION)

FIGURE 31.GERMANY ELECTROCARDIOGRAPH (ECG) MARKET,2020-2030($MILLION)

FIGURE 32.FRANCE ELECTROCARDIOGRAPH (ECG) MARKET,2020-2030($MILLION)

FIGURE 33.UNITED KINGDOM ELECTROCARDIOGRAPH (ECG) MARKET,2020-2030($MILLION)

FIGURE 34.ITALY ELECTROCARDIOGRAPH (ECG) MARKET,2020-2030($MILLION)

FIGURE 35.SPAIN ELECTROCARDIOGRAPH (ECG) MARKET,2020-2030($MILLION)

FIGURE 36.REST OF EUROPE ELECTROCARDIOGRAPH (ECG) MARKET,2020-2030($MILLION)

FIGURE 37.JAPAN ELECTROCARDIOGRAPH (ECG) MARKET,2020-2030($MILLION)

FIGURE 38.CHINA ELECTROCARDIOGRAPH (ECG) MARKET,2020-2030($MILLION)

FIGURE 39.INDIA ELECTROCARDIOGRAPH (ECG) MARKET,2020-2030($MILLION)

FIGURE 40.AUSTRALIA ELECTROCARDIOGRAPH (ECG) MARKET,2020-2030($MILLION)

FIGURE 41.MALAYSIA ELECTROCARDIOGRAPH (ECG) MARKET,2020-2030($MILLION)

FIGURE 42.NEW ZEALAND ELECTROCARDIOGRAPH (ECG) MARKET,2020-2030($MILLION)

FIGURE 43.REST OF ASIA-PACIFIC ELECTROCARDIOGRAPH (ECG) MARKET,2020-2030($MILLION)

FIGURE 44.BRAZIL ELECTROCARDIOGRAPH (ECG) MARKET,2020-2030($MILLION)

FIGURE 45.SOUTH AFRICA ELECTROCARDIOGRAPH (ECG) MARKET,2020-2030($MILLION)

FIGURE 46.EGYPT ELECTROCARDIOGRAPH (ECG) MARKET,2020-2030($MILLION)

FIGURE 47.SAUDI ARABIA ELECTROCARDIOGRAPH (ECG) MARKET,2020-2030($MILLION)

FIGURE 48.REST OF LAMEA ELECTROCARDIOGRAPH (ECG) MARKET,2020-2030($MILLION)

FIGURE 49. TOP WINNING STRATEGIES, BY YEAR

FIGURE 50. TOP WINNING STRATEGIES, BY DEVELOPMENT

FIGURE 51. TOP WINNING STRATEGIES, BY COMPANY

FIGURE 52.PRODUCT MAPPING OF TOP 10 PLAYERS

FIGURE 53.COMPETITIVE DASHBOARD

FIGURE 54.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS

FIGURE 55.NIHON KOHDEN CORPORATION.: NET SALES ,($MILLION)

FIGURE 56.OSI SYSTEMS FUKUDA DENSHI CO LTD..: NET SALES ,($MILLION)

FIGURE 57.OPTO CIRCUITS LIMITED.: NET SALES ,($MILLION)

FIGURE 58.PHILIPS HEALTHCARE (KONINKLIJKE PHILIPS N.V.).: NET SALES ,($MILLION)

FIGURE 59.SCHILLER AG.: NET SALES ,($MILLION)

FIGURE 60.GE HEALTHCARE (GENERAL ELECTRIC COMPANY).: NET SALES ,($MILLION)

FIGURE 61.JOHNSON AND JOHNSON.: NET SALES ,($MILLION)

FIGURE 62.MORTARA INSTRUMENT, INC..: NET SALES ,($MILLION)

FIGURE 63.MEDTRONIC PLC.: NET SALES ,($MILLION)

FIGURE 64.MINDRAY MEDICAL INTERNATIONAL LIMITED.: NET SALES ,($MILLION